With the latest British Lung Foundation report on chronic obstructive pulmonary disorder (COPD) highlighting ‘a worrying picture of substandard care’ for patients in the UK, Vygon is urging clinicians to consider automated oxygen therapy to help those in acute respiratory distress.
According to the recent report by the British Lung Foundation, the standard of care for COPD patients in the UK is substandard. The company's FreeO2 monitor, which was used in clinical trials and studies among over 500 COPD patients, was found to improve optimum oxygen saturation levels by 56% compared to manual monitoring and delivered a 21% cost saving.
Read the full article by Med-Tech Innovation News to find out more: med-technews.com
Posted by:
Cure Talent